Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant926 active trials7 approved drugs44 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,824 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00566644 | Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome | terminated | Phase 3 | 600 | St George's, University of LondonOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00002536 | Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer | completed | Phase 3 | — | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 |
| clinicaltrials |
| NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | completed | Phase 3 | 870 | Gynecologic Oncology GroupNETWORK | 2 | Jul 9, 2013 | clinicaltrials |
| NCT00003691 | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 3 | 240 | Gynecologic Oncology GroupNETWORK | 2 | Jul 9, 2013 | clinicaltrials |
| NCT00003445 | Docetaxel in Treating Patients With Advanced Cancer of the Cervix | completed | Phase 2 | — | Grupo Oncologico Cooperativo del SurOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004082 | Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | completed | Phase 1 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00098995 | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 22 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00023894 | Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 5 | Jun 24, 2013 | clinicaltrials |
| NCT00026260 | SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00049231 | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer | completed | N/A | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00071929 | Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003017 | Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005837 | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 21, 2013 | clinicaltrials |
| NCT00005999 | Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006005 | Thalidomide in Treating Patients With Gynecologic Sarcomas | completed | Phase 2 | — | New York University Cancer InstituteOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00002562 | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | completed | Phase 2 | 25 | Gynecologic Oncology GroupNETWORK | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00049556 | Gefitinib in Treating Patients With Cervical Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00278304 | Radiation Therapy in Treating Patients With Cervical Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005070 | Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jun 19, 2013 | clinicaltrials |
| NCT01880411 | Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine | unknown | Phase 1 | 15 | HealthBanks Biotech Co., Ltd.INDUSTRY | 0 | Jun 19, 2013 | clinicaltrials |
| NCT00006377 | Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00002478 | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00003179 | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer | terminated | Phase 2 | 360 | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00003946 | Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00005643 | Chemotherapy in Treating Patients With Sarcoma of the Uterus | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00005861 | Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00091130 | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells | completed | Phase 2 | 139 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00046969 | Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | completed | Phase 4 | 450 | AGO Study GroupOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00264732 | A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix | completed | Phase 2 / Phase 3 | 251 | Eisai Inc.INDUSTRY | 1 | May 29, 2013 | clinicaltrials |
| NCT00002813 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | completed | Phase 2 | 62 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00003379 | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | completed | Phase 1 / Phase 2 | 40 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00003795 | Quality of Life in Survivors of Gynecologic Cancer | completed | — | 311 | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00003945 | Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | completed | Phase 3 | 400 | Gynecologic Oncology GroupNETWORK | 4 | May 27, 2013 | clinicaltrials |
| NCT00005031 | Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00016926 | Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00053261 | Vaginal Changes and Sexual Function in Patients With Cervical Cancer | completed | — | — | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00276796 | Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | 66 | Gynecologic Oncology GroupNETWORK | 0 | May 27, 2013 | clinicaltrials |
| NCT00099008 | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women | completed | Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT01851928 | Validation of a Nutrition Screening Tool | completed | — | 128 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00005036 | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 560 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00033358 | Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00708942 | Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 | terminated | Phase 2 | 83 | PhotocureINDUSTRY | 3 | Apr 24, 2013 | clinicaltrials |
| NCT01836588 | New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR | unknown | N/A | 300 | Charite University, Berlin, GermanyOTHER | 1 | Apr 22, 2013 | clinicaltrials |
| NCT00002976 | Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer | terminated | Phase 3 | 2,108 | Gynecologic Oncology GroupNETWORK | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00003624 | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00006224 | Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Apr 11, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jul 10, 2013source: clinicaltrials